๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Incidence of Monoclonal Gammopathy of Undetermined Significance and Estimation of Duration Before First Clinical Recognition

โœ Scribed by Terry M. Therneau; Robert A. Kyle; L. Joseph Melton III; Dirk R. Larson; Joanne T. Benson; Colin L. Colby; Angela Dispenzieri; Shaji Kumar; Jerry A. Katzmann; James R. Cerhan; S. Vincent Rajkumar


Book ID
119323300
Publisher
Mayo Clinic
Year
2012
Tongue
English
Weight
535 KB
Volume
87
Category
Article
ISSN
0025-6196

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Monoclonal gammopathy of undetermined si
โœ Gordan Srkalovic; Marte G. Cameron; Lisa Rybicki; Steven R. Deitcher; Kandice Ka ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 320 KB

## Background: Venous thromboembolic disease (vtd) is a recently recognized complication of thalidomide in combination therapy for patients with multiple myeloma (mm). the authors assessed the frequency of vtd and its risk factors in 612 consecutive patients with plasma cell dyscrasia (pcd) who wer

Clinical features, evaluation, and treat
โœ Kenneth C. Gorson ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 32 KB ๐Ÿ‘ 2 views

A number of common disorders of the peripheral nervous system are closely linked to a monoclonal gammopathy. In a minority of patients, the neuropathy represents the sentinel feature of a malignant plasma cell dyscrasia, such as multiple myeloma or its osteosclerotic variant, Waldenstrom's disease,